Enter your information and check the box below to receive a list of facilities and providers near you that offer the Genius® 3D Mammography™ exam.

We’re committed to ending health care disparities.

Hologic recently announced a multi-year commitment to decreasing breast cancer screening disparities for Black women.

The program is in partnership with the Black Women’s Health Imperative (BWHI), the only nonprofit organization created by Black women to help protect and advance the health and wellness of Black women and girls through awareness and education, and RAD-AID, a nonprofit dedicated to ensuring equal access to radiology health services for medically underserved communities.

Learn More

Facts and figures.

  • Black women should start screening at least by age 40 because peak breast cancer for them occurs in the mid 40s, compared to peak in the early 50s for white women.

  • The overall rates of breast cancer in Black and white women are similar, but Black women are 20% to 40% more likely to die from breast cancer.

  • Early detection of breast cancer results in an almost 100% 5-year survival rate.1

Why choose a Genius® exam?

Only the Genius® 3D Mammography™ exam:

  • Is approved by the FDA as a superior mammogram for women with dense breasts.2-3

  • Detects 20-65% more invasive breast cancers, compared to 2D mammography alone.4

  • With the SmartCurve™ system5, reduces the amount of discomfort you feel during your mammogram.6

Welcome to a mammogram that is more accurate and more comfortable.

Visit MyGenius3D.com

Doctor and Patient

* Compared to 2D mammography alone.

  1. Breastcancer.org. US breast cancer statistics. Breastcancer.org. http://www.breastcancer.org/symptoms/understand_bc/statistics. Accessed on: May 25, 2016

  2. Ho JM, Jafferjee N, Covarrubias GM, Ghesani M, Handler B. Dense breasts: a review of reporting legislation and available supplemental screening options. AJR Am J Roentgenol. 203(2):449-56, 2014.

  3. Sprague BL, Gangnon RE, Burt V, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst. 106(10), 2014.

  4. FDA submissions P080003, P080003/S001, P080003/S004, P080003/S005

  5. Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507.

  6. Results from Friedewald, SM, et al. "Breast cancer screening using tomosynthesis in combination with digital mammography." JAMA 311.24 (2014): 2499-2507; a multi-site (13), non-randomized, historical control study of 454,000 screening mammograms investigating the initial impact the introduction of the Hologic Selenia Dimensions on screening outcomes. Individual results may vary. The study found an average 41% increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per 1000 screening exams were found in women receiving combined 2D FFDM and 3D(TM) mammograms acquired with the Hologic 3D Mammography(TM) System versus women receiving 2D FFDM mammograms only.

  7. Bernardi D, Macaskill P, Pellegrini M, et al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.

  8. National Breast Cancer Foundation, Inc. Stages 0 & 1: what does is mean to have stage 1 breast cancer? National Breast Cancer Foundation, Inc. http://www.nationalbreastcancer.org/breast-cancer-stage-0- and-1. Accessed on: March 31, 2015

  9. Not available at all facilities. Please contact your healthcare professional for more information.

  10. Smith, A. Improving Patient Comfort in Mammography. Hologic WP-00019 Rev 003(2017)